Your A-Z of episodes

Did you know there’s even more we can do to promote your episode? Find out more…

  • Episode 189

    The pink-haired CEO

    Emma Banks

    / ramarketing

    Emma Banks, CEO at ramarketing, joined the podcast and spoke on how, despite market headwinds, the pharma services sector is looking up.

  • Episode 188

    The Harvard spin-out disrupting drug discovery

    Rani Powers

    / Pluto Bio

    Rani Powers, Founder & CEO of Pluto Bio, shares how her passion for coding and biology led to Pluto, a platform accelerating drug discovery.

  • Episode 187

    The rare disease champion

    Tamar Thompson

    / Alexion, AstraZeneca Rare Disease

    Tamar Thompson Head of Global Corporate Affairs at Alexion, AstraZeneca Rare Disease, joins the podcast to discuss the value and impact being acquired by AstraZeneca had on Alexion

  • Episode 186

    The VC Biotech investor

    Chris Garabedian

    / Xontogeny

    In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Chris Garabedian, CEO at Xontogeny and Venture Fund Manager at Perceptive Advisors. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Chris, covering: Chris Garabedian founded Xontogeny in June of 2016 to

  • Episode 185

    The diamond in the rough

    Kent Payne

    / Aliri Bioanalysis

    Kent Payne, CEO at Aliri discusses the value of scientists engaging with clients to build relationships and showcase technical expertise.

  • Episode 184

    One-hour special – The President of the PBOA

    Gil Roth

    / Pharma & Biopharma Outsourcing Association (PBOA)

    Gil Roth, PBOA President, joins the podcast to discuss the latest pharma and biopharma industry news, plus green shoots to watch out for.

  • Episode 183

    The puzzle-solving CEO

    Steven Chevillotte

    / SaniSure

    Steven Chevillotte joins Molecule to Market to discuss the key elements that have played a role in the continued success of SaniSure.

  • Episode 182

    Summer sentiment: A life science industry check-in & where you’ll find me

    Raman Sehgal

    / Molecule to Market

    Join Raman Sehgal for a quick update on the life sciences sector’s current state amid market challenges and where to find him on the road.

  • Episode 181

    Pivoting to partnership success in clinical trial

    Yussuf Goolam

    / RxSource

    Yussuf Goolam, Co-Founder, President and CEO of RxSource, recently spoke about his incredible journey into the clinical trials space.

  • Episode 180

    A Sterling, CDMO leader

    Kevin Cook

    / Sterling Pharma Solutions

    Kevin Cook, CEO at Sterling Pharma Solutions spoke on his key tips to mastering M&A and growing exponentially in the North American market.

  • Load more